Cardio diagnostics holdings, inc receives innovative technology contract from vizient for its novel ai-driven precision heart disease tests – epi+gen chd & precisionchd

Chicago--(business wire)--cardio diagnostics today announced its ai-driven molecular heart disease tests has received an innovation technology contract from vizient, inc.

CDIO Ratings Summary

CDIO Quant Ranking